A population-based registry study of patients with advanced ovarian cancer in Hamburg, Germany, found that complete surgical clearance—leaving no macroscopic residual tumour—was associated with substantially better survival and delayed progression in routine clinical practice. The study, published in Archives of Gynecology and Obstetrics, analysed FIGO stage III and IV ovarian cancer patients diagnosed between 2014 and 2024, offering a real-world complement to findings from specialised centres.
The cohort comprised 576 patients with a median age of 65 years and a median follow-up of 57 months. Surgeons achieved no macroscopic residuals in 370 patients, or 64.2% of the cohort. Using Kaplan–Meier functions and Cox proportional hazards models, the researchers estimated associations between surgical outcome and survival.
In multivariable analysis, achieving no macroscopic residuals was associated with a reduced mortality risk (hazard ratio 0.62, 95% confidence interval 0.42–0.90) and a reduced progression risk (hazard ratio 0.68, 95% confidence interval 0.49–0.94). These estimates are observational associations from registry data rather than evidence of a causal effect of surgery itself, and residual disease status may partly reflect underlying tumour biology and patient factors.
Beyond surgical outcome, the analysis identified advanced FIGO stage, poor performance status, and increasing age as independent predictors of worse outcomes, indicating that patient characteristics remain important prognostic factors even after accounting for the completeness of cytoreduction.
The authors concluded that achieving no macroscopic residuals remains a critical prognostic factor in advanced ovarian cancer. They noted that the 64.2% rate demonstrates that optimal surgical outcomes are achievable in routine practice, though opportunities for improvement remain compared with specialised centres. As a single-region registry study, the findings describe surgical quality in one German city over a decade and may not generalise to all health systems.
Subject of Research: Association between surgical completeness and long-term survival in advanced ovarian cancer
Article Title: Surgical quality and long-term outcomes in advanced ovarian cancer: a population based registry study from Hamburg, Germany 2014–2024
Article References: Annemarie, S., Frederik, P., Anna, J., & Barbara, S. (2026). Surgical quality and long-term outcomes in advanced ovarian cancer: a population based registry study from Hamburg, Germany 2014–2024. Archives of Gynecology and Obstetrics, 313(1), Article 302. https://doi.org/10.1007/s00404-026-08578-x
Image Credits: AI Generated
DOI: 10.1007/s00404-026-08578-x
Keywords: ovarian cancer, cytoreductive surgery, macroscopic residuals, registry study, prognosis, survival, FIGO stage III/IV, Germany, Kaplan-Meier, Cox model, Surgical, quality
News Source: Nathaniel Bowman. (October 29, 2026). No Macroscopic Residuals Linked to Better Survival in Advanced Ovarian Cancer Registry Study. Scienmag.
